Stay updated on Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial page.

Latest updates to the Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial page
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedA new revision entry (v3.6.4) was added to the history, replacing the previous v3.6.3. This represents a minor backend or UI update to the page metadata and does not modify study details.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedThe record history now shows Revision: v3.6.3, replacing v3.6.2, indicating the page has been updated in the history timeline. This reflects a refresh of the study record without changing the underlying study data.SummaryDifference0.1%

- Check48 days agoChange DetectedAn added revision label shows Revision: v3.6.2 in the page footer, replacing Revision: v3.6.0. This indicates a software version update for the record history page.SummaryDifference0.1%

- Check63 days agoChange DetectedRecruitment status updated to show that no more participants are being sought. A new revision tag v3.6.0 has been added, replacing the previous v3.5.5.SummaryDifference0.2%

- Check70 days agoChange DetectedThe page history now shows Revision: v3.5.5, replacing v3.5.4. This indicates a deployment update to the history page rather than changes to study data or content.SummaryDifference0.1%

- Check91 days agoChange DetectedThe page footer now shows 'Revision: v3.5.4' replacing 'v3.5.3'. This indicates a minor platform update to the page rendering rather than a change to study data.SummaryDifference0.1%

Stay in the know with updates to Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial page.